Jun 08, 2023 / 01:30PM GMT
Dev Prasad - Jefferies LLC - Analyst
Good morning, everyone. My name is Dev Prasad; I'm a Senior Associate in [Kalishi's] team at Jefferies research. Thank you for attending our conference. It's my pleasure to introduce our Michele Korfin, COO and CCO at Gamida Cell, for our next presentation. Thank you.
Michele Korfin - Gamida Cell Ltd - COO & Chief Commercial Officer
Thank you, Dev. Well, good morning, everyone. As Dev indicated, my name is Michele Korfin; I'm Chief Operating Officer and Chief Commercial Officer at Gamida Cell. I'm joined by my colleague, our CFO, Terry Coelho. During the course of this presentation, I may make forward-looking statements, so I refer you to our latest SEC filing for our risk factors.
So at Gamida Cell, our whole mission is to develop therapies specifically focused, at this point in time, in hematology oncology, although we do have an early-stage study ongoing in aplastic anemia. We have five key pillars that I'll talk about today.
First and foremost, we're incredibly excited. April 17, we received FDA
Gamida Cell Ltd at Jefferies Healthcare Conference Transcript
Feb 07, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers